메뉴 건너뛰기




Volumn 10, Issue 6, 2001, Pages 511-516

Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: Estimates from three US Veterans Affairs Medical Centers

Author keywords

Adverse effects; Congestive heart failure; Depression; Epidemiology; Obstructive lung disease; Postmarketing surveillance; Topical beta blockers

Indexed keywords

AMINOPHYLLINE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; BITOLTEROL; BRONCHODILATING AGENT; CARTEOLOL; CLOMIPRAMINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DIGOXIN; FLUNISOLIDE; IPRATROPIUM BROMIDE; LEVOBUNOLOL; METIPRANOLOL; MONTELUKAST; NEDOCROMIL; ORCIPRENALINE; PIRBUTEROL; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIMOLOL; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

EID: 0035698530     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.634     Document Type: Article
Times cited : (19)

References (10)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.